These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 604119)

  • 1. Field observations on influenza vaccination among horses in Britain, 1971-1976.
    Powell DG; Burrows R; Spooner P; Mumford J; Thomson G
    Dev Biol Stand; 1977 Jun 1-3; 39():347-52. PubMed ID: 604119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible basis of adverse reactions to vaccination against equine influenza.
    Dalgleish R; Love S
    Vet Rec; 1993 Jun; 132(26):658-9. PubMed ID: 8362474
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-reactivity of existing equine influenza vaccines with a new strain of equine influenza virus from China.
    Chambers TM
    Vet Rec; 1992 Oct; 131(17):388-91. PubMed ID: 1333665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for immunity against equine influenza virus infections.
    Bürki F; Lamatsch O
    Comp Immunol Microbiol Infect Dis; 1981; 4(3-4):267-78. PubMed ID: 6174266
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficiency of equine influenza vaccines including tetanus toxoid of combined vaccines].
    Bommeli W; Kihm U; Löhrer J; Fey H
    Schweiz Arch Tierheilkd; 1980 Jan; 122(1):27-37. PubMed ID: 7384775
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
    Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
    Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
    Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
    Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the use of influenza vaccines in horses and the importance of antigenic drift.
    Baker DJ
    Equine Vet J; 1986 Mar; 18(2):93-6. PubMed ID: 3698963
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.
    Chambers TM; Holland RE; Tudor LR; Townsend HG; Cook A; Bogdan J; Lunn DP; Hussey S; Whitaker-Dowling P; Youngner JS; Sebring RW; Penner SJ; Stiegler GL
    Equine Vet J; 2001 Nov; 33(7):630-6. PubMed ID: 11770982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Cross-protection' and 'cross-reaction' with equine influenza vaccines.
    Newton JR; Wood JL; Jessett D; Yates PJ; Mumford JA
    Vet Rec; 1999 Nov; 145(22):647. PubMed ID: 10619614
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against equine herpesvirus 1 and equine influenza infection.
    Witherspoon DM
    Vet Rec; 1984 Oct; 115(14):363. PubMed ID: 6093330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.